Synthetic, Universal Reversal Agent for Heparin Anticoagulants

Science-Business eXchange
doi 10.1038/scibx.2014.1332
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Reversal Agents for Use With Direct and Indirect Anticoagulants

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2016English

Introduction to Direct Oral Anticoagulants and Rationale for Specific Reversal Agents

American Journal of Emergency Medicine
MedicineEmergency Medicine
2016English

Reversal of Direct Oral Anticoagulants in Hemophilia Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

The Reversal of Direct Oral Anticoagulants in Animal Models

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2017English

Monitoring Effects of Oral Anticoagulants During Treatment With Heparin.

BMJ
1984English

Reversal of Direct Oral Anticoagulants for Liver Transplantation in Cirrhosis: A Step Forward

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Reversal of Direct Oral Anticoagulants: Guidance From the Anticoagulation Forum

American Journal of Hematology
Hematology
2019English

Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents

American Journal of Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy